FDA Submission of an IVD Assay and Collection Device For SARS-CoV- 2/Flu/RSV

Award Notice Posted

Solicitation number
75A50121P00022
Agency
Awarded
to Hologic, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75A50121P00022 Federal contract award
Place of performance
San Diego CA 92121 USA

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services announces a contract awarded to Hologic, Inc. on January 15, 2021 for $114,146,717. The contract requires Hologic, Inc. to submit an in vitro diagnostic assay and collection device for SARS-CoV-2/flu/RSV testing to the Food and Drug Administration. The justification for unusual and compelling urgency cites the ongoing COVID-19 public health emergency and national emergency declared on March 13, 2020.

Notice text

This justification for unusual and compelling urgency is due to the public health emergency caused by COVID-19, which was declared a global pandemic by the WHO. The first confirmed case of COVID-19 in the United States was announced on January 21, 2020 and a national emergency was declared via Presidential Proclamation on March 13, 2020. The ultimate spread, length of time, and severity of the COVID-19 outbreak is unknown as this time and current data indicate that COVID-19 has begun to spread exponentially, in the typical pattern for an epidemic. The goal of the ongoing U.S. public health response is to respond to and mitigate sustained spread of COVID-19 in this country.

Awarded contract 75A50121P00022 to HOLOGIC, INC. for 11414617.00 on 2021-01-15.

Files

File Type Posted
Class J and A Final 3.21.20.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors